Page last updated: 2024-11-05

thiotepa and Alopecia

thiotepa has been researched along with Alopecia in 4 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Alopecia: Absence of hair from areas where it is normally present.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Champagne, C1
Taylor, M1
Farrant, P1
de Jonge, ME1
Mathôt, RA1
Dalesio, O1
Huitema, AD1
Rodenhuis, S1
Beijnen, JH1
Legha, SS1
Ajani, JA1
Blumenschein, GR1
Hortobagyi, GN1
Buzdar, AU1
Calvert, W1

Other Studies

4 other studies available for thiotepa and Alopecia

ArticleYear
Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure.
    Clinical and experimental dermatology, 2015, Volume: 40, Issue:5

    Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Humans; Primary O

2015
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
    Bone marrow transplantation, 2002, Volume: 30, Issue:9

    Topics: Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carbo

2002
Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.
    Cancer, 1984, May-01, Volume: 53, Issue:9

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms;

1984
Alopecia and cytotoxic drugs.
    British medical journal, 1966, Oct-01, Volume: 2, Issue:5517

    Topics: Alopecia; Female; Humans; Ovarian Neoplasms; Thiotepa

1966